Ted Skolarus to Medical Oncology
This is a "connection" page, showing publications Ted Skolarus has written about Medical Oncology.
Connection Strength
1.734
-
Estimating the Size and Scope of the Urologic Oncology Clinical Trials Enterprise. Urol Pract. 2024 07; 11(4):627-629.
Score: 0.664
-
Using implementation science to improve urologic oncology care. Urol Oncol. 2016 09; 34(9):384-7.
Score: 0.386
-
Rethinking Patient-Physician Communication of Biopsy Results--The Waiting Game. JAMA Oncol. 2015 Nov; 1(8):1025-6.
Score: 0.368
-
Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019. Urol Oncol. 2025 May; 43(5):335.e9-335.e15.
Score: 0.171
-
Early National Dissemination of Abiraterone and Enzalutamide for Advanced Prostate Cancer in Medicare Part D. J Oncol Pract. 2017 08; 13(8):e694-e702.
Score: 0.103
-
Prevalence of unnecessary kidney function exclusion criteria in urologic oncology clinical trials. Urol Oncol. 2024 12; 42(12):452.e15-452.e19.
Score: 0.043